Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Genetics

• Publication date

  2012-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cancergen.2012.04.002PMID 22682623PMCID PMC3655764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diet and breast cancer

  2022cited by this paper
• National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology

  2012cited by this paper
• History Shaped the Geographic Distribution of Genomic Admixture on the Island of Puerto Rico

  2011influential reference
• A pilot study of knowledge and interest of genetic counseling and testing for hereditary breast and ovarian cancer syndrome among Puerto Rican women

  2011cited by this paper
• Genetic/familial high-risk assessment: breast and ovarian.

  2010cited by this paper
• Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry

  2009influential reference
• Performance of BRCA1/2 mutation prediction models in Asian Americans.

  2008cited by this paper
• Management of an inherited predisposition to breast cancer.

  2007cited by this paper
• Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.

  2007cited by this paper
• Clinical practice. Management of an inherited predisposition to breast cancer.

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia

  2007cited by this paper
• BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.

  2007influential reference
• Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian Cancer: Recommendations of the National Society of Genetic Counselors

  2007influential reference
• The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis.

  2006cited by this paper
• BRCA1 and BRCA2 mutations in a South American population.

  2006influential reference
• Understanding breast cancer risk ‐ where do we stand in 2005?

  2005cited by this paper
• Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological research.

  2005cited by this paper
• Reconstructing the population history of Puerto Rico by means of mtDNA phylogeographic analysis.

  2005influential reference
• Prevalence of BRCA Mutations and Founder Effect in High-Risk Hispanic Families

  2005cited by this paper
• Does Genetic Counseling Have Any Impact on Management of Breast Cancer Risk?

  2005cited by this paper
• Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement

  2005cited by this paper
• Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype–phenotype correlations

  2005cited by this paper
• Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.

  2005cited by this paper
• Genetic admixture and asthma‐related phenotypes in Mexican American and Puerto Rican asthmatics

  2005cited by this paper
• Molecular analysis of the eighteen most frequent mutations in the BRCA1 gene in 63 Chilean breast cancer families.

  2004influential reference
• Recognition and management of hereditary breast cancer syndromes.

  2004cited by this paper
• Identification of germline 185delAG BRCA1 mutations in non‐Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado

  2004cited by this paper
• BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study.

  2004cited by this paper
• Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.

  2004cited by this paper
• Genetic Cancer Risk Assessment and Counseling: Recommendations of the National Society of Genetic Counselors

  2004influential reference
• Effects of a cancer genetics education programme on clinician knowledge and practice

  2004cited by this paper
• Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival

  2004cited by this paper
• Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations

  2004cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• Trends in Breast Cancer by Race and Ethnicity

  2003cited by this paper
• Identification of germline 185delAG BRCA1 mutations in non‐Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado

  2003cited by this paper
• Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis.

  2003cited by this paper
• Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects

  2003cited by this paper
• Nutrition and Lifestyle Factors on the Risk of Developing Breast Cancer

  2003cited by this paper
• Differences in breast cancer stage, treatment, and survival by race and ethnicity.

  2003cited by this paper
• Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

  2003cited by this paper
• American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

  2003cited by this paper
• Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis.

  2002cited by this paper
• Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: Implications for genetic testing

  2002cited by this paper
• BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

  2002cited by this paper
• Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women.

  2002cited by this paper
• Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

  2002influential reference
• BRCA1 and BRCA2 mutation analysis of early‐onset and familial breast cancer cases in Mexico

  2002cited by this paper
• Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.

  2002cited by this paper
• Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer.

  2001cited by this paper
• Diet and breast cancer

  2001cited by this paper
• The Breast Cancer Information Core: Database design, structure, and scope

  2000cited by this paper
• Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.

  2000cited by this paper
• Frequency of germ‐line BRCA1 mutations among Spanish families from a Mediterranean area

  2000cited by this paper
• Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.

  1999cited by this paper
• Cancer risks in BRCA2 mutation carriers.

  1999cited by this paper
• Identification of a novel splice‐site mutation of the BRCA1 gene in two breast cancer families: Screening reveals low frequency in Icelandic breast cancer patients

  1998cited by this paper
• Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

  1998cited by this paper
• Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.

  1998cited by this paper
• Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia.

  1997cited by this paper
• A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.

  1997cited by this paper
• The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.

  1997cited by this paper
• BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

  1997cited by this paper
• A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing.

  1997cited by this paper
• The genetic attributable risk of breast and ovarian cancer

  1996cited by this paper
• A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

  1996cited by this paper
• Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

  1996cited by this paper
• Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.

  1996cited by this paper
• Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer

  1996cited by this paper
• Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

  1995cited by this paper
• The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

  1995cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1994cited by this paper

• Germline Genetic Variants in Cancer Predisposition Genes in Patients From Latin America and the Caribbean.

  2025cites this paper
• A Rare Case of Triple-Negative Breast Cancer with RAD51D Gene Mutation

  2024cites this paper
• Management and Clinical Outcomes of Breast Cancer in Women Diagnosed with Hereditary Cancer Syndromes in a Clinic-Based Sample from Colombia

  2024cites this paper
• Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling

  2023cites this paper
• Teratogenicity

  2022cites this paper
• Identification of a RAD52 Inhibitor Inducing Synthetic Lethality in BRCA2-Deficient Cancer Cells

  2021cites this paper
• SNPs in the interleukin-12 signaling pathway are associated with breast cancer risk in Puerto Rican women

  2020cites this paper
• BRCA gene mutations: A population based review

  2019cites this paper
• Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy

  2019cites this paper
• Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico

  2019cites this paper
• A Recurrent BRCA2 Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico

  2018cites this paper
• BRCA1 mutation spectrum, functions, and therapeutic strategies: The story so far.

  2018cites this paper
• The importance of BRCA 1 and BRCA 2 genes mutations in breast cancer development

  2018cites this paper
• Identification of a novel breast cancer-causing mutation in the BRCA1 gene by targeted next generation sequencing: A case report.

  2018cites this paper
• Breast Cancer Research in the Caribbean: Analysis of Reports From 1975 to 2017

  2018cites this paper
• Genetics, tumor features and treatment response of breast cancer in Latinas

  2018cites this paper
• Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical–pathological features in BRCA carriers and non-carriers

  2017cites this paper
• Genetic Cancer Risk Assessment for Breast Cancer in Latin America.

  2017cites this paper
• Chapter 62 – Teratogenicity

  2017cites this paper
• Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients

  2017cites this paper
• Hereditary cancer syndromes in Latino populations: genetic characterization and surveillance guidelines

  2017cites this paper
• Clinical Cancer Genetics Disparities among Latinos

  2017cites this paper
• State of Art of Cancer Pharmacogenomics in Latin American Populations

  2017cites this paper
• Frecuencia de las mutaciones en los genes BRCA en mujeres con agregación familiar de cáncer de glándula mamaria/ovario

  2016cites this paper
• Genomic Disparities in Breast Cancer Among Latinas.

  2016cites this paper
• The importance of BRCA1 and BRCA2 genes mutations in breast cancer development

  2016cites this paper
• Improving cancer clinical research and trials with Hispanic populations: training and outreach efforts between Moffitt Cancer Center and the Ponce School of Medicine.

  2015cites this paper
• Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2

  2015cites this paper
• Common BRCA1 and BRCA2 Mutations among Latin American Breast Cancer Subjects: A Meta-Analysis

  2015cites this paper
• Genetic counseling for hereditary breast and ovarian cancer among Puerto Rican women living in the United States.

  2015cites this paper
• The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective

  2015influential citation
• Frecuencia de mutación y de variantes de secuencia para los genes BRCA1 y BRCA2 en una muestra de mujeres colombianas con sospecha de síndrome de cáncer de mama hereditario: serie de casos

  2015cites this paper
• Frecuencia de mutación y de variantes de secuencia para los genes BRCA1 y BRCA2 en una muestra de mujeres colombianas con sospecha de síndrome de cáncer de mama hereditario: serie de casos

  2015cites this paper
• When a Common Language Is Not Enough: Transcreating Cancer 101 for Communities in Puerto Rico

  2015cites this paper
• Don't neglect cultural diversity in oncology care.

  2014cites this paper
• A Comprehensive Focus on Global Spectrum of BRCA1 and BRCA2 Mutations in Breast Cancer

  2013cites this paper
• A Comprehensive Literature Analysis of Causes and Treatment Options for Hereditary Breast Cancer

  2013cites this paper